Our broad aim is to develop targeted therapies for childhood cancer that are not only more effective than current therapies but also safer to use in children, causing fewer side effects.
Our approach involves:
- Identifying and validating new molecular targets.
- Discovering and optimising new drugs or combinations.
- Developing realistic pre-clinical systems to model clinical activity.
- Ultimately establishing clinical trials to test new targeted therapies.
Our goal is to develop new therapies for childhood brain cancers that can be rapidly translated into the clinic.
Drug Discovery Centre
Our work centres on discovering new anti-cancer therapeutics and supporting personalised medicine for children with cancer.
We are working on developing effective treatments for children with neuroblastoma.
Metal-Targeted Therapy and Immunology
We study the role of metals in cancer, with a view to developing new therapies and imaging protocols.